Cargando…
Glycine increases fat‐free mass in malnourished haemodialysis patients: a randomized double‐blind crossover trial
BACKGROUND: Protein energy wasting is associated with negative outcome in patients under chronic haemodialysis (HD). Branched‐chain amino acids (BCAAs) may increase the muscle mass. This post hoc analysis of a controlled double‐blind randomized crossover study assessed the impact of BCAAs on nutriti...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718019/ https://www.ncbi.nlm.nih.gov/pubmed/34519439 http://dx.doi.org/10.1002/jcsm.12780 |
_version_ | 1784624631862263808 |
---|---|
author | Genton, Laurence Teta, Daniel Pruijm, Menno Stoermann, Catherine Marangon, Nicola Mareschal, Julie Bassi, Isabelle Wurzner‐Ghajarzadeh, Arelene Lazarevic, Vladimir Cynober, Luc Cani, Patrice D. Herrmann, François R. Schrenzel, Jacques |
author_facet | Genton, Laurence Teta, Daniel Pruijm, Menno Stoermann, Catherine Marangon, Nicola Mareschal, Julie Bassi, Isabelle Wurzner‐Ghajarzadeh, Arelene Lazarevic, Vladimir Cynober, Luc Cani, Patrice D. Herrmann, François R. Schrenzel, Jacques |
author_sort | Genton, Laurence |
collection | PubMed |
description | BACKGROUND: Protein energy wasting is associated with negative outcome in patients under chronic haemodialysis (HD). Branched‐chain amino acids (BCAAs) may increase the muscle mass. This post hoc analysis of a controlled double‐blind randomized crossover study assessed the impact of BCAAs on nutritional status, physical function, and quality of life. METHODS: We included 36 chronic HD patient features of protein energy wasting as plasma albumin <38 g/L, and dietary intakes <30 kcal/kg/day and <1 g protein/kg/day. Patients received either oral BCAA (2 × 7 g/day) or glycine (2 × 7 g/day) for 4 months (Period 1), followed by a washout period of 1 month, and then received the opposite supplement (Period 2). The outcomes were lean body mass measured by dual‐energy X‐ray absorptiometry, fat‐free mass index measured by bioelectrical impedance, resting energy expenditure, dietary intake and appetite rating, physical activity and function, quality of life, and blood parameters. Analyses were performed by multiple mixed linear regressions including type of supplementation, months, period, sex, and age as fixed effects and subjects as random intercepts. RESULTS: Twenty‐seven patients (61.2 ± 13.7 years, 41% women) were compliant to the supplementations (consumption >80% of packs) and completed the study. BCAA did not affect lean body mass index and body weight, but significantly decreased fat‐free mass index, as compared with glycine (coeff −0.27, 95% confidence interval −0.43 to −0.10, P = 0.002, respectively). BCAA and glycine intake had no effect on the other clinical parameters, blood chemistry tests, or plasma amino acids. CONCLUSIONS: Branched‐chain amino acid did not improve lean body mass as compared with glycine. Unexpectedly, glycine improved fat‐free mass index in HD patients, as compared with BCAA. Whether long‐term supplementation with glycine improves the clinical outcome remains to be demonstrated. |
format | Online Article Text |
id | pubmed-8718019 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87180192022-01-06 Glycine increases fat‐free mass in malnourished haemodialysis patients: a randomized double‐blind crossover trial Genton, Laurence Teta, Daniel Pruijm, Menno Stoermann, Catherine Marangon, Nicola Mareschal, Julie Bassi, Isabelle Wurzner‐Ghajarzadeh, Arelene Lazarevic, Vladimir Cynober, Luc Cani, Patrice D. Herrmann, François R. Schrenzel, Jacques J Cachexia Sarcopenia Muscle Original Articles BACKGROUND: Protein energy wasting is associated with negative outcome in patients under chronic haemodialysis (HD). Branched‐chain amino acids (BCAAs) may increase the muscle mass. This post hoc analysis of a controlled double‐blind randomized crossover study assessed the impact of BCAAs on nutritional status, physical function, and quality of life. METHODS: We included 36 chronic HD patient features of protein energy wasting as plasma albumin <38 g/L, and dietary intakes <30 kcal/kg/day and <1 g protein/kg/day. Patients received either oral BCAA (2 × 7 g/day) or glycine (2 × 7 g/day) for 4 months (Period 1), followed by a washout period of 1 month, and then received the opposite supplement (Period 2). The outcomes were lean body mass measured by dual‐energy X‐ray absorptiometry, fat‐free mass index measured by bioelectrical impedance, resting energy expenditure, dietary intake and appetite rating, physical activity and function, quality of life, and blood parameters. Analyses were performed by multiple mixed linear regressions including type of supplementation, months, period, sex, and age as fixed effects and subjects as random intercepts. RESULTS: Twenty‐seven patients (61.2 ± 13.7 years, 41% women) were compliant to the supplementations (consumption >80% of packs) and completed the study. BCAA did not affect lean body mass index and body weight, but significantly decreased fat‐free mass index, as compared with glycine (coeff −0.27, 95% confidence interval −0.43 to −0.10, P = 0.002, respectively). BCAA and glycine intake had no effect on the other clinical parameters, blood chemistry tests, or plasma amino acids. CONCLUSIONS: Branched‐chain amino acid did not improve lean body mass as compared with glycine. Unexpectedly, glycine improved fat‐free mass index in HD patients, as compared with BCAA. Whether long‐term supplementation with glycine improves the clinical outcome remains to be demonstrated. John Wiley and Sons Inc. 2021-09-14 2021-12 /pmc/articles/PMC8718019/ /pubmed/34519439 http://dx.doi.org/10.1002/jcsm.12780 Text en © 2021 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Genton, Laurence Teta, Daniel Pruijm, Menno Stoermann, Catherine Marangon, Nicola Mareschal, Julie Bassi, Isabelle Wurzner‐Ghajarzadeh, Arelene Lazarevic, Vladimir Cynober, Luc Cani, Patrice D. Herrmann, François R. Schrenzel, Jacques Glycine increases fat‐free mass in malnourished haemodialysis patients: a randomized double‐blind crossover trial |
title | Glycine increases fat‐free mass in malnourished haemodialysis patients: a randomized double‐blind crossover trial |
title_full | Glycine increases fat‐free mass in malnourished haemodialysis patients: a randomized double‐blind crossover trial |
title_fullStr | Glycine increases fat‐free mass in malnourished haemodialysis patients: a randomized double‐blind crossover trial |
title_full_unstemmed | Glycine increases fat‐free mass in malnourished haemodialysis patients: a randomized double‐blind crossover trial |
title_short | Glycine increases fat‐free mass in malnourished haemodialysis patients: a randomized double‐blind crossover trial |
title_sort | glycine increases fat‐free mass in malnourished haemodialysis patients: a randomized double‐blind crossover trial |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718019/ https://www.ncbi.nlm.nih.gov/pubmed/34519439 http://dx.doi.org/10.1002/jcsm.12780 |
work_keys_str_mv | AT gentonlaurence glycineincreasesfatfreemassinmalnourishedhaemodialysispatientsarandomizeddoubleblindcrossovertrial AT tetadaniel glycineincreasesfatfreemassinmalnourishedhaemodialysispatientsarandomizeddoubleblindcrossovertrial AT pruijmmenno glycineincreasesfatfreemassinmalnourishedhaemodialysispatientsarandomizeddoubleblindcrossovertrial AT stoermanncatherine glycineincreasesfatfreemassinmalnourishedhaemodialysispatientsarandomizeddoubleblindcrossovertrial AT marangonnicola glycineincreasesfatfreemassinmalnourishedhaemodialysispatientsarandomizeddoubleblindcrossovertrial AT mareschaljulie glycineincreasesfatfreemassinmalnourishedhaemodialysispatientsarandomizeddoubleblindcrossovertrial AT bassiisabelle glycineincreasesfatfreemassinmalnourishedhaemodialysispatientsarandomizeddoubleblindcrossovertrial AT wurznerghajarzadeharelene glycineincreasesfatfreemassinmalnourishedhaemodialysispatientsarandomizeddoubleblindcrossovertrial AT lazarevicvladimir glycineincreasesfatfreemassinmalnourishedhaemodialysispatientsarandomizeddoubleblindcrossovertrial AT cynoberluc glycineincreasesfatfreemassinmalnourishedhaemodialysispatientsarandomizeddoubleblindcrossovertrial AT canipatriced glycineincreasesfatfreemassinmalnourishedhaemodialysispatientsarandomizeddoubleblindcrossovertrial AT herrmannfrancoisr glycineincreasesfatfreemassinmalnourishedhaemodialysispatientsarandomizeddoubleblindcrossovertrial AT schrenzeljacques glycineincreasesfatfreemassinmalnourishedhaemodialysispatientsarandomizeddoubleblindcrossovertrial |